Endocrinology and metabolism Archives - Page 3 of 6

Glucocorticoid management of adrenal insufficiency in the UK: Assessment using real-world data

Authors: K Iqbal, K Halsby, R D Murray, P V Carroll, R Petermann Published: Endocrine Connections, 2018 View publication Background and objectives Glucocorticoids are used to manage adrenal insufficiency (AI). We describe...

A retrospective observational study of patients with type 1 diabetes with self-reported severe hypoglycaemia reveals high level of ambulance attendance but low levels of therapy change and specialist intervention

Authors: Rahul Nayar, Benjamin Field,, Anne Kilvert, Mike Baxter, Joseph Hickey, Michael Cummings, Stephen Bain Published: Diabetic medicine: a journal of the British Diabetic Association, 2017 View publication Aim To evaluate the...

Defining the characteristics of chronic hypoparathyroidism not adequately controlled on conventional therapy: Consensus findings of three European delphi panels

Authors: K Iqbal, N Dass, C Gip, J Vila, AJ Rylands, C Marelli Published: 2019 View publication Introduction European Society of Endocrinology (ESE) guidelines provide goals for hypoparathyroidism management but do not...

A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA)

Authors: T Pang, S C Bain, R Neil, A Black, J G Boyle, J Elliott, A Holcombe, K C S Lee, C Mulligan, L Saunders, A Yousseif and M Baxter Published: 2018...

A Delphi panel in the UK to define patients with chronic hypoparathyroidism ‘not adequately controlled on standard therapy’

Authors: A Rylands, K Patel, N Dass, K Iqbal Published: Endocrine Abstracts, 2017 View publication Abstract Chronic hypoparathyroidism (HypoPT) is a rare endocrine condition characterised by hypocalcaemia and deficient or absent parathyroid...

A retrospective observational study of people with Type 1 diabetes with self‐reported severe hypoglycaemia reveals high level of ambulance attendance but low levels of therapy change and specialist intervention

Authors: B C T Field, R Nayar, A Kilvert, M Baxter, J Hickey, M Cummings, S C Bain Published: Diabetic Medicine, 2018 View publication Aim To evaluate the impact of severe hypoglycaemia...

Collecting real-world data from patients with Type 1 diabetes in the United Kingdom to complement evidence from randomised clinical trials: SPARTA, a multi-centred, observational, retrospective research study of insulin glargine 300U/mL (Gla-300)

Authors: T Pang, M Baxter, J Hickey, H Schou Published: Diabetic Medicine: A Journal of the British Diabetic Association, 2018 View publication

Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1 diabetes and parents of youth

Authors: J T Markowitz, K Pratt, J Aggarwal, L K Volkening, L M Laffel Published: Diabetes Technology and Therapeutics, 2012 View publication Background Continuous glucose monitoring (CGM) has been shown to improve...

Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder

Authors: B G Verheggen, R Lee, M M Lieuw On, M J Treur, M F Botteman, S A Kaplan, J N Trocio Published: Journal of Medical Economics, 2012 View publication Objective A...

News